Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Clover Biopharmaceuticals Ltd. ( (HK:2197) ) is now available.
Clover Biopharmaceuticals Ltd. announced changes to its board of directors and committee memberships, effective July 1, 2025. Dr. Donna Marie Ambrosino and Mr. Xiang Liao have been appointed as members of the Nomination Committee, reflecting the company’s ongoing efforts to strengthen its governance structure.
More about Clover Biopharmaceuticals Ltd.
Clover Biopharmaceuticals Ltd. is a company incorporated in the Cayman Islands, focusing on the biopharmaceutical industry. It is involved in the development and commercialization of innovative vaccines and biologic therapeutic products.
Average Trading Volume: 1,252,715
Technical Sentiment Signal: Hold
Current Market Cap: HK$376.1M
Find detailed analytics on 2197 stock on TipRanks’ Stock Analysis page.